AMRYT PHARMA LTD - SPNR ADR
COMMON EQUITY
CUSIP: 03217L106
Institutional Holders1
Total Institutional Value$0
Total Shares Held0
Avg Position$0
Top 5 Holders %0.0%
Top 15 Institutional Holders by Value
■ New ■ Increased ■ Decreased ■ Unchanged
Institutional Holders — Q4 25
| Manager | Alpha | Flow | Value | Shares | Change |
|---|---|---|---|---|---|
| GLOBAL FRONTIER INVESTMENTS LLC | High Conviction | Minimal Flow | $0 (0%) | 0 | - |
Implied Institutional Price History
Estimated from 13F aggregate market value ÷ shares reported across all institutional filers. Reflects quarter-end snapshot, not actual trade prices.
| Quarter | Filers | Institutional Value | Shares Held | Est. Avg Price |
|---|---|---|---|---|
| Q1 23 | 83 | $0.67B | 63,035,947 | $10.68 |
| Q4 22 | 57 | $0.27B | 45,799,920 | $5.89 |
| Q3 22 | 55 | $0.01B | 45,621,109 | $0.31 |
| Q2 22 | 55 | $0.01B | 48,630,101 | $0.29 |
| Q1 22 | 61 | $0.02B | 44,430,793 | $0.38 |
| Q4 21 | 53 | $0.02B | 36,288,518 | $0.60 |
| Q3 21 | 59 | $0.05B | 33,700,374 | $1.44 |
| Q2 21 | 27 | $0.02B | 17,799,007 | $1.38 |
Source: SEC 13F-HR filings. Implied price = aggregate market value ÷ shares reported. Not investment advice.